Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Reexamination Certificate
2008-07-15
2008-07-15
Shiao, Rei-Tsang (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
C514S102000, C558S155000, C558S084000, C558S156000
Reexamination Certificate
active
07399756
ABSTRACT:
The present invention describes organophosphorus compounds of general formula (I)their preparation and their uses in the activation of gamma/delta T-cells, in the screening of GcpE and LytB enzyme inhibitors and in the prophylaxis and treatment of diseases in humans and animals.
REFERENCES:
patent: 5639653 (1997-06-01), Bloom et al.
patent: 5902793 (1999-05-01), Bloom et al.
patent: 6534050 (2003-03-01), Tanaka et al.
patent: 6624151 (2003-09-01), Belmant et al.
patent: 6660723 (2003-12-01), Belmant et al.
patent: 2334711 (2000-12-01), None
patent: 2444955 (2003-10-01), None
patent: 11718 (2005-01-01), None
patent: WO 95/20673 (1995-08-01), None
patent: WO 00/00182 (2000-01-01), None
patent: WO 00 30653 (2000-06-01), None
patent: WO 00 59916 (2000-10-01), None
patent: WO 01/22816 (2001-04-01), None
patent: WO 01/94561 (2001-12-01), None
patent: WO 02/12478 (2002-02-01), None
patent: WO 02/083720 (2002-10-01), None
patent: WO 02/095011 (2002-11-01), None
patent: WO 03/038072 (2003-05-01), None
Lensky et al., 1999, CAS:130:191901.
Brown et al., 1997, CAS: 128:30414.
Belmant et al., 2000, CAS: 133:276336.
Hintz et al., 2001, CAS: 136:165676.
Schwender, J. “Die Mevalonat-unabhangige Isoprenoid-Biosynthese und•deren Verbreitung in Pflanzen”, Dissertation, Nov. 10, 1999, pp. I-X and 1-168.
Belmant, C. et al. “3-Formyl-1-butyl pyrophosphate a novel mycobacterial metabolite-activating human gamma delta T cells”J. Biol. Chem, 1999, pp. 32079-32084, vol. 274, No. 45.
Takagi, M. et al. “Studies on the nomevalonate pathway: Formation of 2-C-methyl-D-erythritol 2,4-cyclodiphosphate from 2-phospho-4(cytidine 5′-diphospho)-2-C-methyl-D-erythritol”Tetrahedron Letters, 2000, pp. 3395-3398, vol. 41.
Tanaka, Y. et al. “Natural and synthetic non-peptide antigens recognized by human gamma delta T cells”Nature, May 11, 1995, pp. 155-158, vol. 375, No. 6527.
McClard, R.W. et al. “Novel phosphonylphosphinyl (P-C-P-C-) analogues of biochemically interesting diphosphates. Syntheses and properties of P-C-P-C-, analogues of isopentenyl diphosphate and dimethylallyl diphosphate”J. Am. Chem. Soc., 1987, pp. 5544-5545, vol. 109.
Jacob, L. et al. “On the influence of phosphoric ester groups in geranyldiphosphate biosynthesis”Bull. Soc. Chim. de France, 1990, pp. 719-733, vol. 127, No. 6.
Sireci, G. et al. “Differential activation of human gamma delta cells by nonpeptide phosphoantigens”Eur. J. Immunol., 2001, pp. 1628-1635, vol. 31.
Belmant, C. et al. “A chemical basis for selective recognition of nonpeptide antigens by human delta T cells”FASEB J., Sep. 2000, pp. 1669-1670, vol. 14.
Hintz, M. et al. “Identification of (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate as a major activator for human gamma delta T cells inEscherichia coli” FEBS Lett., 2001, pp. 317-322, vol. 509.
Feurle, J. et al. “Echericheria coliproduces phosphoantigens activating human gamma delta T cells”J. Biol. Chem., Jan. 4, 2002, pp. 148-154, vol. 277, No. 1.
Espinosa, E. “Synaptic transfer by human gamma delta T cells stimulated with soluble or cellular antigens”J. Immunol., 2002, pp. 6336-6343, vol. 168.
Gao, W. et al. “(E)-4-hydroxy-3-methylbut-2-enyl diphosphate: An intermediate in the formation of terpenoids in plant Chromoplasts”Angew. Chem Int. Ed., 2002, pp. 2604-2607, vol. 41, No. 14.
Fox, D.T. et al. “Synthesis of (E)-4-hydroxydimethylallyl diphosphate. An intermediate in the methyl erythritol phosphate branch of the isoprenoid pathway”J. Org. Chem., 2002, pp. 5009-5010, vol. 67, No. 14.
O'Brien, R.S. et al. “Depletion of a γδ T cell subset can increase host resistance to a bacterial infection”J. Immunol., 2000, pp. 6472-6479, vol. 165.
Schwender, J. “Die mevalonat-unabhängige isoprenoid-biosynthese und deren verbreitung in pflanzen”Dissertation, Universität Karlsruhe(TH) Nov. 10, 1999.
Santini, D. et al. “The antineoplastic role of bisphosphonates: from basic research to clinical evidence”Ann. Oncol., 2003, pp. 1468-1476, vol. 14.
Espinosa, E. et al. “Chemical synthesis and biological activity of bromohydrin pyrophosphate, a potent stimulator of human γδ T cells”J. Biol. Chem., May 25, 2001, pp. 18337-18344, vol. 276, No. 21.
Brondino, C. et al. “Synthesis of new phosphonic derivatives with fluorinated chains”J. Fluorine Chem., 1996, pp. 193-200, vol. 76.
Kunzmann, V. et al. “Stimulation of γδ T cells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma”Blood, Jul. 15, 2000, pp. 384-392, vol. 96, No. 2.
Valentijn, A.R.P.M. et al. “An expeditious synthesis of pyrophosphate analogues of farnesyl pyrophosphate using the phosphonylating agent methyl methylphosphonomorpholidate”Synlett, Sep. 1991, pp. 663-664.
Beytia, E.D. et al. “Biochemistry of polyisoprenoid biosynthesis”Annu. Rev. Biochem., 1976, pp. 113-142, vol. 45.
Rohmer, M. “The discovery of a mevalonate-independent pathway for isoprenoid biosynthesis in bacteria, algae and higher plants”Nat. Prod. Rep., 1999, pp. 565-574, vol. 16.
Jomaa, H. et al. “Vγ9/Vδ2 T cell activation induced by bacterial low molecular mass compounds depends on the 1-deoxy-D-xylulose 5-phosphate pathway of isoprenoid biosynthesis”FEMS Immunol. and Med. Microbiol., 1999, pp. 371-378, vol. 25.
Ward, J.L. et al. “Synthesis of (2E)-4-hydroxy-3-methylbut-2-enyl diphosphate, a key intermediate in the biosynthesis of isoprenoids”J. Chem. Soc., Perkin Trans. 1, 2002, pp. 710-712.
Seemann, M. et al. “Isoprenoid biosynthesis inEscherichia colivia the methylerythritol phosphate pathway: enzymatic conversion of methylerythritol cyclodiphosphate into a phosphorylated derivative of (E)-2-methylbut-2-en3-1,4-diol”Tetrahedron Lett., 2002, pp. 1413-1415, vol. 43.
Woodside, A.B. et al. “Trisammonium geranyl diphosphate”Org. Synth., 1988, pp. 211-219, vol. 66.
Sato, K. et al. “A new synthesis of α-santalol”Bull. Chem. Soc. Jpn., 1976, pp. 3351-3352, vol. 49, No. 11.
Hiroi, K. et al. “Palladium-catalyzed intramolecular metallo-ene reactions using allylic sulfones as enophiles”Chem. Pharm. Bull., 1994, pp. 786-791, vol. 42, No. 4.
Altincicek Boran
Eberl Matthias
Hintz Martin
Jomaa Hassan
Kollas Ann-Kristin
Bioagency AG
Saliwanchik Lloyd & Saliwanchik
Shiao Rei-tsang
LandOfFree
Organo-phosphorous compounds for activating gamma/delta T cells does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Organo-phosphorous compounds for activating gamma/delta T cells, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Organo-phosphorous compounds for activating gamma/delta T cells will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2811212